Mizuho Maintains Buy on MiMedx Group, Raises Price Target to $12
Portfolio Pulse from Benzinga Newsdesk
Mizuho analyst Anthony Petrone maintains a Buy rating on MiMedx Group (NASDAQ:MDXG) and raises the price target from $10 to $12.
August 04, 2023 | 11:04 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Mizuho maintains a Buy rating on MiMedx Group and raises the price target from $10 to $12.
The news of Mizuho maintaining a Buy rating and raising the price target for MiMedx Group is likely to have a positive impact on the company's stock in the short term. Investors may see this as a sign of confidence in the company's future performance, which could drive up demand for the stock.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100